Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300408	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31					view
JYHZ2300409	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31					view
JYHZ2300410	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31					view
JYHB2200292	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-06-14					view
JYHB2200293	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-06-14					view
JYHB2101628	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-01-05					view
JYHB2101627	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-01-05					view
JYHB2101629	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-12-30					view
JYHB2101420	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-09-16					view
JYHB2101419	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-09-16					view
JYHB2100101	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-01-29	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2021-01-28	view
JYHB2001446	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2020-08-21	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Filed	2020-09-01	view
JYHZ1900157	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2019-07-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-11-25	view
JYHZ1900158	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2019-07-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-11-25	view
JYHZ1800391	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2018-11-30	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-05-24	view
CYHS1700711	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs(4)	Generic Drug	2018-05-30	长风药业股份有限公司	CF PharmTech Inc	In Review	2018-05-28	view